scispace - formally typeset
J

Jörg Reichenwallner

Researcher at Martin Luther University of Halle-Wittenberg

Publications -  14
Citations -  264

Jörg Reichenwallner is an academic researcher from Martin Luther University of Halle-Wittenberg. The author has contributed to research in topics: Human serum albumin & Electron paramagnetic resonance. The author has an hindex of 7, co-authored 12 publications receiving 211 citations. Previous affiliations of Jörg Reichenwallner include Max Planck Society & University of Toronto.

Papers
More filters
Journal ArticleDOI

Evidence for Water-Tuned Structural Differences in Proteins: An Approach Emphasizing Variations in Local Hydrophilicity

TL;DR: Differences in amino acid hydropathies of specific structural regions in both proteins can be used to correlate the observed difference in the global (tertiary) solution structures with the differences on the primary structure level.
Journal ArticleDOI

Using bound fatty acids to disclose the functional structure of serum albumin.

TL;DR: A new electron paramagnetic resonance (EPR) spectroscopic approach is devised to gain information on the functional structure of serum albumin in solution in a "coarse-grained" manner from the ligands' point of view, indicating increased surface flexibility and plasticity for HSA in solution.
Journal ArticleDOI

Dendronized albumin core-shell transporters with high drug loading capacity.

TL;DR: Dendronized G2-DHSA-doxorubicin displayed significant cytotoxicity resulting from high drug loading and high stability under different conditions, thus demonstrating its great potential as a transporter for drug molecules.
Journal ArticleDOI

Modeling excluded volume effects for the faithful description of the background signal in double electron-electron resonance.

TL;DR: It is suggested that the delineated simultaneous analysis procedure can be generally applied to reduce ambiguities related to the ill-posed extraction of distance distributions from DEER spectra.
Journal ArticleDOI

Characterizing Active Pharmaceutical Ingredient Binding to Human Serum Albumin by Spin-Labeling and EPR Spectroscopy.

TL;DR: The contribution of functional groups (FGs) in a compound on its albumin-binding capabilities is quantitatively described and new drug modifications with predictable protein binding tendency may be envisaged.